Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome

NCT02670525 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
338
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute